SciDEX Analysis: 2026 04 01 Gap 005

Computational notebook for SDA-2026-04-01-gap-005

SDA
📊 Related Analysis: 4R-tau strain-specific spreading patterns in PSP vs CBD (neurodegeneration)
Created: 2026-04-04
Download .ipynb
4R-tau strain-specific spreading patterns in PSP vs CBD — SciDEX Notebook

4R-tau strain-specific spreading patterns in PSP vs CBD

Analysis ID: SDA-2026-04-01-gap-005

Generated: 2026-04-02 | Platform: SciDEX | Layer: Agora + Forge

---

import numpy as np
import matplotlib.pyplot as plt
from scipy import stats
import warnings
warnings.filterwarnings('ignore')
print('Environment ready.')
Environment ready.

1. Hypothesis Ranking

The multi-agent debate generated 7 hypotheses, scored across 10 dimensions.

RankHypothesisTarget GeneScore
1Aquaporin-4 Polarization RescueAQP40.464
2Microglial Purinergic ReprogrammingP2RY120.463
3Complement C1q Subtype SwitchingC1QA0.425
4Sphingolipid Metabolism ReprogrammingCERS20.423
5Glial Glycocalyx Remodeling TherapyHSPG20.395
6Ephrin-B2/EphB4 Axis ManipulationEPHB40.379
7Netrin-1 Gradient RestorationNTN10.307

2. Score Comparison

# Hypothesis composite scores bar chart
plt.show()

3. Multi-Dimensional Score Radar

Radar plot comparing top hypotheses across all 10 scoring dimensions.

# Multi-dimensional scoring radar
plt.show()

4. Differential Gene Expression Analysis

Simulated expression analysis for 7 target genes comparing disease vs. control.

# Volcano plot: Differential expression
plt.show()

5. Pathway Enrichment Analysis

Enrichment analysis identifies biological pathways overrepresented among target genes.

# Pathway enrichment bar chart
plt.show()

6. Statistical Analysis

Comprehensive statistical testing of hypothesis scores.

# Statistical summary
from scipy import stats
print(summary)
============================================================
STATISTICAL SUMMARY
============================================================
Hypotheses: 7
Composite — Mean: 0.4078, Median: 0.4226, Std: 0.0507, Range: [0.3067, 0.4639]
Novelty   — Mean: 0.7786, Std: 0.0846
Feasibility — Mean: 0.5457, Std: 0.1729
Novelty-Feasibility Pearson r=-0.6186 (p=0.1387) Not significant
============================================================

7. Debate Highlights

Unknown

Novel Therapeutic Hypotheses for 4R-Tau Strain-Specific Spreading in PSP vs CBD

1. Glial Glycocalyx Remodeling Therapy

Description: PSP and CBD tau strains differentially interact with region-specific glial glycocalyx compositions, determining astrocytic morphology. Enzymatic remodeling of heparan sulfate proteoglycans could redirect pathological tau from forming tufted astrocytes (PSP) to less toxic configurations.

Target: HSPG2 (perlecan), EXT1/EXT2 (heparan sulfate biosynthesis...

Unknown

I'll provide a rigorous critique of each hypothesis, examining the evidence gaps and methodological concerns.

Critical Evaluation of Tau Strain-Specific Therapeutic Hypotheses

1. Glial Glycocalyx Remodeling Therapy

Specific Weaknesses:

  • The cited evidence (PMID: 31064851, 28334866) addresses general tau-HSPG interactions, not strain-specific differences between PSP and CBD tau
  • No direct evidence that heparan sulfate binding differences translate to therapeutic efficacy
  • Assumes c...
  • Unknown

    Druggability Assessment of Tau Strain-Specific Therapeutic Hypotheses

    1. Glial Glycocalyx Remodeling Therapy

    Druggability: MODERATE

  • HSPG2/EXT1/EXT2: Limited druggability. EXT1/EXT2 are intracellular enzymes requiring small molecule penetration
  • Chemical matter: Heparanase inhibitors exist (SST0001, necuparanib) but are non-selective
  • Existing compounds:

  • SST0001 (roneparstat): Phase II trials for multiple myeloma (NCT02194985)
  • Necuparanib: Phase I/II for panc...
  • Unknown

    ```json { "ranked_hypotheses": [ { "title": "Microglial Purinergic Reprogramming", "description": "P2Y12 receptor expression levels determine whether microglia promote tufted astrocyte formation (low P2Y12) versus astrocytic plaques (high P2Y12) by controlling ATP-mediated tau propagation signals. Selective P2Y12 modulation could redirect pathology.", "target_gene": "P2RY12", "dimension_scores": { "mechanistic_plausibility": 0.7, "evidence_strength":...

    8. Key Citations

    This analysis cited 20 papers:

  • PMID: 32160082 - The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting auto (Autophagy, 2021)
  • PMID: 34571885 - Beyond Activation: Characterizing Microglial Functional Phenotypes. (Cells, 2021)
  • PMID: 41814722 - [Advantageous therapeutic pathways and mechanisms of Jianpi Huogu Formula in tre (Zhongguo Zhong Yao Za Zhi, 2026)
  • PMID: 41825304 - P2 purinergic receptors in systemic lupus erythematosus: from experimental findi (Curr Opin Immunol, 2026)
  • PMID: 41843422 - Differences in mRNA expression of neuroinflammation-related genes in the tempora (Epileptic Disord, 2026)
  • PMID: 41898413 - Clopidogrel Administration Impairs Neurovascular Unit Recovery and Exacerbates A (Int J Mol Sci, 2026)
  • PMID: 41924777 - Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects (Biochem Biophys Res Commun, 2026)
  • PMID: 35847503 - Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition o (Acta Pharm Sin B, 2022)
  • PMID: 38383790 - IL-10 constrains sphingolipid metabolism to limit inflammation. (Nature, 2024)
  • PMID: 38961186 - PAQR4 regulates adipocyte function and systemic metabolic health by mediating ce (Nat Metab, 2024)
  • PMID: 39792658 - Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and (Sci Adv, 2025)
  • PMID: 40624017 - EMP1 safeguards hematopoietic stem cells by suppressing sphingolipid metabolism (Nat Commun, 2025)
  • PMID: 18164103 - Interactions between the products of the Herpes simplex genome and Alzheimer's d (Neurochem Int, 2008)
  • PMID: 34433968 - APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans. (Nature, 2021)
  • PMID: 37582915 - Spatial transcriptomics reveal markers of histopathological changes in Duchenne (Nat Commun, 2023)
  • ---

    Generated: 2026-04-02 | Platform: SciDEX | Layer: Agora + Forge

    This notebook was auto-generated from the SciDEX multi-agent debate pipeline.


    Generated by SciDEX — scidex.ai